1. Approval of un-audited financial results of the Company, on standalone basis, as at/for the quarter and three months ended September 30th 2024, in accordance with Regulation 33 of SEBI (Listing Obligation and Disclosure) Requirements) Regulations, 2015 and taking on record the Limited Review Report issued by the Statutory Auditor of the Company (copy attached as Annexure A). 2. Appointment of Mrs. Pallavi Garg (ACS- 69848) as the Company Secretary & Compliance Officer of the Company.

pdf

Kimia Biosciences Ltd.

12 Nov 2024

41.26

-4.05%

Board Meeting

Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Notice Of Board Meeting - November …

BSE India

Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, the 14th day of November, 2024, to inter-alia consider, approve and take on record the Un- Audited Financial Results of the Company for the Second Quarter (Q2) and Half year ended September 30, 2024, of the Financial Year 2024-25, duly reviewed (Limited Review) by the Statutory Auditors of the Company.

pdf

Kimia Biosciences Ltd.

10 Oct 2024

41.26

-4.05%

Company Update

Kimia Biosciences Ltd - 530313 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Dear Sir/ Madam, Pursuant to Regulation 74(5) of SEBI (Depositories and Participants Regulations, 2018, please find enclosed a copy of certificate for the quarter and half year ended September 30, 2024 received from RTA.

pdf

Kimia Biosciences Ltd.

30 Sep 2024

41.26

-4.05%

SAST

Kimia Biosciences Ltd - 530313 - Closure of Trading Window

BSE India

Dear Sir/ Madam, Pursuant to Company''s code of Prevention of Insider Trading, the trading window in securities of the Company shall remain closed from Tuesday, October 01, 2024 till the expiry of 48 hours after the declaration of un-audited financial results standalone for the quarter ended September 30, 2024. The date of Board Meeting for declaration of un-audited financial results of the Company for quarter and half year ending September 30, 2024 will be intimated in due course.

pdf

Kimia Biosciences Ltd.

17 Sep 2024

41.26

-4.05%

Company Update

Kimia Biosciences Ltd - 530313 - Clarification Letter

BSE India

In reference to your email dated September 17, 2024, requesting additional details regarding the order from your esteemed office, please find attached copies of the purchase orders from the following entities: 1. Wereldwijde Chemicalien 2. Pichi Pacha Both entities are located in the Netherlands, and the purchase orders contain comprehensive details of the products procured, including quantities and pricing. We trust that the information provided will meet your requirement Thank you for your taking this on record.

pdf

Kimia Biosciences Ltd.

16 Sep 2024

41.26

-4.05%

Company Update

Kimia Biosciences Ltd - 530313 - Intimation Of Approval For Extension Of Time To Conduct Annual …

BSE India

We wish to inform you that our Company has submitted an application to the Registrar of Companies, Delhi & NCT, under Section 96 of the Companies Act, 2013, requesting an extension for holding the Annual General Meeting (AGM) that was initially due on or before September 30, 2024. We are pleased to inform you that the Registrar of Companies, Delhi & NCT, has granted an extension of three months to conduct the AGM of FY 2023-24. Consequently, the Company will convene the AGM within this extended timeframe. The specific date for the AGM will be communicated in due course following approval by the Board of Directors. You are requested to take this information into your records.

pdf

Kimia Biosciences Ltd.

16 Sep 2024

41.26

-4.05%

Company Update

Kimia Biosciences Ltd - 530313 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - …

BSE India

Pursuant to Regulation 30 of the SEBI LODR 2015, we are pleased to inform you that Kimia Biosciences Limited has been awarded a contract by a reputed client based in Europe. The Total Value of the Contract is USD 200,000/- (US Dollar Two Lakhs Only). The Contract is related to Contract Development and manufacturing Organisations (CDMO) and is epected to contribute significantly to the Company''s revenue for current financial year.

pdf

Kimia Biosciences Ltd.

20 Aug 2024

41.26

-4.05%

Result

Kimia Biosciences Ltd - 530313 - Unaudited Financial Results For The Quarter Ended On 30Th June2024

BSE India

Unaudited financial Results for the quarter ended on 30th June,2024.

pdf

Kimia Biosciences Ltd.

20 Aug 2024

41.26

-4.05%

Company Update

Kimia Biosciences Ltd - 530313 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to the Regulation 30 of the Securities and Exchange Board of India ( Listing Obligation and Disclosure Requirements) Regulations, 2015. Please find attached Newspaper Publications of Un-Audited Financial Results for the Quarter and Three Months ended June,30,2024 in following News Papers 1. Financial Express ( New Delhi)- English Version and Jansatta( New Delhi) in Hindi Version.

pdf

No results found

Is Kimia Biosciences Ltd. worth buying?

14 Votes:

Buy 71.43%

Sell 7.14%

Hold 21.43%

29.34% Fall from 52W High

High volume today

Kimia Biosciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Kimia Biosciences Ltd. from all sources in a single place.